These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
612 related articles for article (PubMed ID: 9274524)
81. Association of Epstein-Barr virus (EBV) with Sjögren's syndrome: differential EBV expression between epithelial cells and lymphocytes in salivary glands. Wen S; Shimizu N; Yoshiyama H; Mizugaki Y; Shinozaki F; Takada K Am J Pathol; 1996 Nov; 149(5):1511-7. PubMed ID: 8909241 [TBL] [Abstract][Full Text] [Related]
82. Variable expression of Epstein-Barr virus latent membrane protein I in Reed-Sternberg cells of Hodgkin's disease. Teramoto N; Cao L; Kawasaki N; Tonoyama Y; Sarker AB; Yoshino T; Takahashi K; Akagi T Acta Med Okayama; 1996 Oct; 50(5):267-70. PubMed ID: 8914680 [TBL] [Abstract][Full Text] [Related]
83. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. Tierney RJ; Steven N; Young LS; Rickinson AB J Virol; 1994 Nov; 68(11):7374-85. PubMed ID: 7933121 [TBL] [Abstract][Full Text] [Related]
84. Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Anagnostopoulos I; Hummel M; Kreschel C; Stein H Blood; 1995 Feb; 85(3):744-50. PubMed ID: 7530505 [TBL] [Abstract][Full Text] [Related]
85. [Anti-apoptotic function of the Epstein-Barr virus LMP1 and BHRF1 proteins]. Kawanishi M Nihon Rinsho; 1996 Jul; 54(7):1848-54. PubMed ID: 8741677 [TBL] [Abstract][Full Text] [Related]
86. Characterization of Epstein-Barr virus-infected cells in benign lymphadenopathy of patients seropositive for human immunodeficiency virus. Brousset P; Schlaifer D; Roda D; Massip P; Marchou B; Delsol G Hum Pathol; 1996 Mar; 27(3):263-8. PubMed ID: 8600041 [TBL] [Abstract][Full Text] [Related]
87. EBV infection of T cells: potential role in malignant transformation. Kelleher CA; Dreyfus DH; Jones JF; Gelfand EW Semin Cancer Biol; 1996 Aug; 7(4):197-207. PubMed ID: 8946604 [TBL] [Abstract][Full Text] [Related]
88. Detection of a nuclear antigen 2 (EBNA2)-variant Epstein-Barr virus strain in two siblings with fatal lymphoproliferative disease. Schuster V; Seidenspinner S; Kreth HW J Med Virol; 1996 Jan; 48(1):114-20. PubMed ID: 8825720 [TBL] [Abstract][Full Text] [Related]
89. Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. Kawaguchi H; Miyashita T; Herbst H; Niedobitek G; Asada M; Tsuchida M; Hanada R; Kinoshita A; Sakurai M; Kobayashi N J Clin Invest; 1993 Sep; 92(3):1444-50. PubMed ID: 8397226 [TBL] [Abstract][Full Text] [Related]
90. Biochemical and genetic studies of Epstein-Barr virus latent membrane protein 2. Longnecker R Leukemia; 1994 Apr; 8 Suppl 1():S46-50. PubMed ID: 8152303 [TBL] [Abstract][Full Text] [Related]
91. Epstein-Barr virus infection and replication in a human epithelial cell system. Li QX; Young LS; Niedobitek G; Dawson CW; Birkenbach M; Wang F; Rickinson AB Nature; 1992 Mar; 356(6367):347-50. PubMed ID: 1312681 [TBL] [Abstract][Full Text] [Related]
92. [Detection of Epstein-Barr virus in the tonsils in infectious mononucleosis]. Sauerbrei A; Färber I; Wutzler P; Swoboda R; Schneider J Laryngorhinootologie; 1990 Feb; 69(2):70-3. PubMed ID: 2157451 [TBL] [Abstract][Full Text] [Related]
93. The nuclear chaperone nucleophosmin escorts an Epstein-Barr Virus nuclear antigen to establish transcriptional cascades for latent infection in human B cells. Liu CD; Chen YL; Min YL; Zhao B; Cheng CP; Kang MS; Chiu SJ; Kieff E; Peng CW PLoS Pathog; 2012; 8(12):e1003084. PubMed ID: 23271972 [TBL] [Abstract][Full Text] [Related]
94. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis). Tosato G; Straus S; Henle W; Pike SE; Blaese RM J Immunol; 1985 May; 134(5):3082-8. PubMed ID: 2984282 [TBL] [Abstract][Full Text] [Related]
95. In vitro Epstein-Barr virus infection model of rabbit lymphocytes from peripheral blood or spleen. Kanai K; Kato K; Sano H; Nagata K; Okuno K; Kuwamoto S; Higaki H; Sugihara H; Kato M; Murakami I; Hayashi K Intervirology; 2011; 54(1):17-24. PubMed ID: 20689312 [TBL] [Abstract][Full Text] [Related]
96. Inhibition of Epstein-Barr virus-induced growth proliferation by a nuclear antigen EBNA2-TAT peptide. Farrell CJ; Lee JM; Shin EC; Cebrat M; Cole PA; Hayward SD Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4625-30. PubMed ID: 15070768 [TBL] [Abstract][Full Text] [Related]
97. New characterization of infectious mononucleosis and a phenotypic comparison with Hodgkin's disease. Reynolds DJ; Banks PM; Gulley ML Am J Pathol; 1995 Feb; 146(2):379-88. PubMed ID: 7531953 [TBL] [Abstract][Full Text] [Related]
98. Molecular Methods for Detecting Epstein-Barr Virus (Part I) : In Situ Hybridization to Epstein-Barr Virus-Encoded RNA (EBER) Transcripts. Fan H; Gulley ML Methods Mol Med; 2001; 49():301-11. PubMed ID: 21370148 [TBL] [Abstract][Full Text] [Related]
99. Epstein-Barr virus (EBV) in infectious mononucleosis: detection of the virus in tonsillar B lymphocytes but not in desquamated oropharyngeal epithelial cells. Niedobitek G; Agathanggelou A; Steven N; Young LS Mol Pathol; 2000 Feb; 53(1):37-42. PubMed ID: 10884920 [TBL] [Abstract][Full Text] [Related]
100. Interleukin-21 regulates expression of key Epstein-Barr virus oncoproteins, EBNA2 and LMP1, in infected human B cells. Konforte D; Simard N; Paige CJ Virology; 2008 Apr; 374(1):100-13. PubMed ID: 18222514 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]